Deborah Cohen on Muck Rack

Deborah Cohen

Chicago
As seen in: MSN UK, BBC, Daily Mail, Irish Daily Mail, Reuters, Scottish Daily Mail, The Independent (UK), USA Today, Wiley Online Library, Yahoo Canada and
Independent writer and communications professional. Former journalist for Reuters, Crain’s Chicago Business, Bloomberg News.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Deborah

Contact Deborah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

How the internet has hijacked our health — as ‘snake oil’ experts offer algorithmic diagnoses

|
By Deborah Cohen
| Aol Verified
Ellie Matthews, a 20-something HR manager, had been struggling with bloating and digestive issues when she spoke to me for my book “Bad Influence: How the Internet Hijacked our Health.” Her primary care physician had just 15 minutes to see her. He’d ordered a battery of scans, stool samples and blood work that all came back normal. At the end of the appointment, he asked her if she was vegan — she was, but didn’t see the relevance — and he told her there was nothing wrong.
Open in Who Shared Issue with article?

A Framework for Evaluating Primary Care Investment

|
By Kevin Grumbach, Deborah Cohen, Stephanie Gold
| Milbank Quarterly in Conversation
Getting your Trinity Audio player ready... Despite a robust body of evidence demonstrating that strong primary care is foundational to a high-performing health system associated with improved population health, greater equity, and lower overall costs, primary care in the US suffers chronic underinvestment. The United States currently spends only 4 to 5 cents on primary care for every dollar spent on health care.
Open in Who Shared Issue with article?

Galleri cancer tests: Controversial NHS trial fails to meet key goal

|
By Deborah Cohen
| The BMJ Verified
A controversial blood test that promises to detect multiple cancers in their early stages failed to meet a key trial endpoint of a significant reduction in stage III-IV cases. Investors in the US company that makes the test, Grail, were told of the results of the multimillion “landmark NHS-Galleri trial” last week. The results could put in jeopardy a deal whereby the NHS would buy millions of the tests and Grail would build a state of the art facility in the UK.
Open in Who Shared Issue with article?
See all 80 licensed articles (118 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified